Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine (original) (raw)

Nature Medicine volume 9, pages 13–14 (2003)Cite this article

A vaccine that is able to work as a treatment for HIV-infected patients has been an elusive goal. Now experiments on macaques suggest that injections of modified dendritic cells might boost immunity to hold back disease progression (pages 27–32).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Human dendritic cell containing HIV-1.

Courtesy of Marie Larsson

References

  1. Rosenberg, E.S. et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523–526 (2000).
    Article CAS Google Scholar
  2. Altfeld, M. et al. HIV-1 superinfection despite broad CD8+ T cell responses containing replication of the primary virus. Nature 420, 434–439 (2002).
    Article CAS Google Scholar
  3. Oxenius, A. et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. USA 99, 13747–13752 (2002).
    Article CAS Google Scholar
  4. Lu, W., Wu, X., Lu, Y., Weizhong, G. & Andrieu, J. Therapeutic dendritic-cell vaccine for simian AIDS. Nature Med. 9, 27–32 (2003).
    Article CAS Google Scholar
  5. Schmitz, J.E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860 (1999).
    Article CAS Google Scholar
  6. Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991–998 (1999).
    Article CAS Google Scholar
  7. Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447–1450 (1997).
    Article CAS Google Scholar
  8. Parren, P.W., Moore, J.P., Burton, D.R. & Sattentau, Q.J. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity. Aids 13 (Suppl. A), S137–162 (1999).
    CAS PubMed Google Scholar
  9. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
    Article CAS Google Scholar
  10. Rossio, J.L. et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72, 7992–8001 (1998).
    CAS PubMed PubMed Central Google Scholar
  11. Bender, A., Bui, L.K., Feldman, M.A., Larsson, M. & Bhardwaj, N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 182, 1663–1671 (1995).
    Article CAS Google Scholar
  12. Bhardwaj, N., Young, J.W., Nisanian, A.J., Baggers, J. & Steinman, R.M. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178, 633–642 (1993).
    Article CAS Google Scholar
  13. Dhodapkar, M.V. et al. Rapid generation of broad T-cell immunity in humans after a single injection of maturation dendritic cells. J. Clin. Invest. 104, 173–180 (1999).
    Article CAS Google Scholar
  14. Ludewig, B. et al. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J. Immunol. 163, 1839–1844 (1999).
    CAS PubMed Google Scholar
  15. Altfeld, M. et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193, 169–180 (2001).
    Article CAS Google Scholar
  16. Barouch, D.H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415, 335–339 (2002).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. The New York University and the Rockefeller University, New York, New York
    Nina Bhardwaj
  2. Partners AIDS Research Center Massachusetts General Hospital, and Division of AIDS Harvard Medical School, Boston, Massachusetts, USA
    Bruce D. Walker

Authors

  1. Nina Bhardwaj
    You can also search for this author inPubMed Google Scholar
  2. Bruce D. Walker
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Bhardwaj, N., Walker, B. Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine.Nat Med 9, 13–14 (2003). https://doi.org/10.1038/nm0103-13

Download citation

This article is cited by